showed that the expression of FOXM1 was upregulated in the 5-FU nonresponsive CRC patients and inhibition of FOXM1 resensitized resistant CRC cells to 5-FU treatment through regulating ABCC10 expression. Here, ABCC10 is linked to colorectal carcinoma.